Tamarack Advisers’s ICU Medical ICUI Stock Holding History

Tamarack Advisers’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,000	Closed	-$495K	–	38
2023 Q1	$495K	Sell	3,000 -2,000	-40%	-$344K	0.18%	34
2022 Q4	$787K	Sell	5,000 -10,000	-67%	-$1.52M	0.41%	31
2022 Q3	$2.26M	Buy	15,000 +2,000	+15%	+$333K	1.33%	24
2022 Q2	$2.14M	Buy	+13,000	New	+$2.5M	1.24%	23
2021 Q4	–	Sell	-35,000	Closed	-$8.17M	–	53
2021 Q3	$8.17M	Buy	35,000 +1,000	+3%	+$210K	2.58%	17
2021 Q2	$7M	Sell	34,000 -36,000	-51%	-$7.41M	1.98%	24
2021 Q1	$14.4M	Sell	70,000 -3,000	-4%	-$634K	2.95%	14
2020 Q4	$15.5M	Buy	73,000 +12,000	+20%	+$2.33M	3.22%	13
2020 Q3	$11.1M	Sell	61,000 -17,000	-22%	-$3.2M	3.44%	13
2020 Q2	$14.4M	Buy	78,000 +67,000	+609%	+$13.3M	4%	7
2020 Q1	$2.22M	Sell	11,000 -59,000	-84%	-$11.4M	0.84%	26
2019 Q4	$13M	Buy	70,000 +35,000	+100%	+$6.02M	2.97%	16
2019 Q3	$5.59M	Buy	+35,000	New	+$6.97M	1.46%	18

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tamarack Advisers's ICUI Position: Q2 2023 in Review

Tamarack Advisers sold out of ICU Medical (ICUI) in Q2 2023, closing a stake of 3,000 shares — an estimated $495K sold.

Tamarack Advisers first reported a position in ICUI in Q3 2019 and held it in 13 quarters. The position peaked at $15.5M in Q4 2020. 231 funds tracked by Wall St. Rank hold ICUI as of Q2 2023.

Tamarack Advisers reported no remaining ICU Medical position as of Q2 2023 after selling out during the quarter.
Tamarack Advisers sold 3,000 ICU Medical shares in Q2 2023, an estimated $495K.
Tamarack Advisers first reported a position in ICU Medical in Q3 2019 and held it in 13 quarters.
Tamarack Advisers's ICU Medical position peaked at $15.5M in Q4 2020.
231 funds tracked by Wall St. Rank held ICU Medical as of Q2 2023.

Based on Tamarack Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.